These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Monitoring the activation state of the insulin-like growth factor-1 receptor and its interaction with protein tyrosine phosphatase 1B using bioluminescence resonance energy transfer. Blanquart C; Boute N; Lacasa D; Issad T Mol Pharmacol; 2005 Sep; 68(3):885-94. PubMed ID: 15976035 [TBL] [Abstract][Full Text] [Related]
7. Ethanol inhibits insulin expression and actions in the developing brain. de la Monte SM; Xu XJ; Wands JR Cell Mol Life Sci; 2005 May; 62(10):1131-45. PubMed ID: 15870954 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of in vivo breast cancer growth by antisense oligodeoxynucleotides to type I insulin-like growth factor receptor mRNA involves inactivation of ErbBs, PI-3K/Akt and p42/p44 MAPK signaling pathways but not modulation of progesterone receptor activity. Salatino M; Schillaci R; Proietti CJ; Carnevale R; Frahm I; Molinolo AA; Iribarren A; Charreau EH; Elizalde PV Oncogene; 2004 Jul; 23(30):5161-74. PubMed ID: 15122317 [TBL] [Abstract][Full Text] [Related]
10. The role of epidermal growth factor receptor in ethanol-mediated inhibition of activator protein-1 transactivation. Ma C; Bower KA; Lin H; Chen G; Huang C; Shi X; Luo J Biochem Pharmacol; 2005 Jun; 69(12):1785-94. PubMed ID: 15878157 [TBL] [Abstract][Full Text] [Related]
12. Involvement of p42/44 MAPK in the effects of ethanol on secretion of insulin-like growth factor (IGF)-I and insulin-like growth factor binding protein (IGFBP)-1 in primary cultured rat hepatocytes. Lee SM; Alam R; Ho CJ; Kim JH; Kang CW; Park JH; Lee MS Int J Neurosci; 2007 Feb; 117(2):187-201. PubMed ID: 17365107 [TBL] [Abstract][Full Text] [Related]
13. Decrease in the insulin receptor protein level by anti-insulin receptor antibodies: roles of tyrosine kinase activity and receptor internalization. Fujita N; Yamasaki H; Yamakawa K; Uotani S; Kuwahara H; Degawa-Yamauchi M; Abe T; Ozaki M; Sera Y; Kawasaki E; Takino H; Yamaguchi Y; Eguchi K Acta Diabetol; 2002 Dec; 39(4):221-7. PubMed ID: 12486497 [TBL] [Abstract][Full Text] [Related]
14. Tyrosine kinase inhibition: an approach to drug development. Keyse SM Hum Exp Toxicol; 1995 Jul; 14(7):618-9. PubMed ID: 7576826 [No Abstract] [Full Text] [Related]
15. Endoplasmic reticulum stress and autophagy dysregulation in alcoholic and non-alcoholic liver diseases. Kim YS; Kim SG Clin Mol Hepatol; 2020 Oct; 26(4):715-727. PubMed ID: 32951410 [TBL] [Abstract][Full Text] [Related]
16. Chronic heavy alcohol consumption influences the association between genetic variants of GCK or INSR and the development of diabetes in men: A 12-year follow-up study. Jang HB; Go MJ; Park SI; Lee HJ; Cho SB Sci Rep; 2019 Dec; 9(1):20029. PubMed ID: 31882596 [TBL] [Abstract][Full Text] [Related]
17. Titrating Tipsy Targets: The Neurobiology of Low-Dose Alcohol. Cui C; Koob GF Trends Pharmacol Sci; 2017 Jun; 38(6):556-568. PubMed ID: 28372826 [TBL] [Abstract][Full Text] [Related]
18. Modulation of Insulin Sensitivity of Hepatocytes by the Pharmacological Downregulation of Phospholipase D. Babenko NA; Kharchenko VS Int J Endocrinol; 2015; 2015():794838. PubMed ID: 26089893 [TBL] [Abstract][Full Text] [Related]